Testing effectiveness (Phase 2)Study completedNCT02222558What this trial is testingOral Testosterone for the Treatment of Hypogonadism in MalesWho this might be right forHypogonadism TesoRx Pharma, LLC 25
Large-scale testing (Phase 3)Ended earlyNCT00831233What this trial is testingSymptomatic Study Investigating Degarelix in Patients Suffering From Prostate CancerWho this might be right forProstate Cancer Ferring Pharmaceuticals 42
Large-scale testing (Phase 3)Active Not RecruitingNCT03070886What this trial is testingAntiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by SurgeryWho this might be right forStage I Prostate Adenocarcinoma AJCC v7Stage II Prostate Adenocarcinoma AJCC v7Stage III Prostate Adenocarcinoma AJCC v7 NRG Oncology 612
Testing effectiveness (Phase 2)Looking for participantsNCT06286397What this trial is testingTopical Anti-Androgens in Pilonidal Sinus DiseaseWho this might be right forPilonidal DiseasePilonidal Disease of Natal CleftPilonidal Sinus+1 more University of Pennsylvania 75
Not applicableStudy completedNCT00341965What this trial is testingPesticide Exposure and Health Status in North Carolina African American Male Farmers and Farm WorkersWho this might be right forPesticide Exposure National Institute of Environmental Health Sciences (NIEHS) 275
Not applicableStudy completedNCT00343031What this trial is testingEffect of the Antiandrogen DDE on Anthropometric Measures at BirthWho this might be right forDDT National Institute of Environmental Health Sciences (NIEHS) 2,118
Early research (Phase 1)UnknownNCT01239888What this trial is testingOxytocin and Tibolone Adjuncts in Treatment Resistant Depression - A Pilot StudyWho this might be right forDepressionMajor Depressive Disorder The Alfred 15
Large-scale testing (Phase 3)Ended earlyNCT00014586What this trial is testingBicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate CancerWho this might be right forProstate Cancer European Organisation for Research and Treatment of Cancer - EORTC 110
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07268794What this trial is testingCONVERT-HB1: Radical Prostatectomy After Systemic Therapy for High-volume Metastatic Hormone-sensitive Prostate CancerWho this might be right forMetastatic Prostate CancerProstate Cancer (Adenocarcinoma)Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Fudan University 112
Large-scale testing (Phase 3)Study completedNCT05126628What this trial is testingThe South Proxa-Rescue AndroCoV Trial Against COVID-19Who this might be right forCOVID-19 Corpometria Institute 133
Large-scale testing (Phase 3)Active Not RecruitingNCT05288166What this trial is testingAbemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)Who this might be right forProstatic NeoplasmsNeoplasm MetastasisUrogenital Neoplasms+14 more Eli Lilly and Company 925
Post-approval studies (Phase 4)UnknownNCT04248621What this trial is testingAndrogen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer PatientsWho this might be right forProstatic Neoplasms Wonju Severance Christian Hospital 164
Large-scale testing (Phase 3)Study completedNCT04728802What this trial is testingProxalutamide Treatment for Hospitalized COVID-19 PatientsWho this might be right forCovid19SARS (Severe Acute Respiratory Syndrome) Applied Biology, Inc. 645
Large-scale testing (Phase 3)Study completedNCT02608450What this trial is testingEvaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25)Who this might be right forAcne Vulgaris Cassiopea SpA 708
Large-scale testing (Phase 3)Study completedNCT02081300What this trial is testingSafety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or HypogonadismWho this might be right forMale Hypogonadism Lipocine Inc. 315
Testing effectiveness (Phase 2)Active Not RecruitingNCT03902951What this trial is testingAntiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate CancerWho this might be right forMetastatic Prostate AdenocarcinomaProstate Adenocarcinoma With Focal Neuroendocrine DifferentiationRecurrent Prostate Carcinoma+1 more Jonsson Comprehensive Cancer Center 28
Not applicableStudy completedNCT04446429What this trial is testingAnti-Androgen Treatment for COVID-19Who this might be right forCOVID-19SARS-CoV2Androgenetic Alopecia+3 more Applied Biology, Inc. 268
Testing effectiveness (Phase 2)UnknownNCT03899077What this trial is testingRadiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RPWho this might be right forCancer of Prostate Cancer Research Antwerp 202
Large-scale testing (Phase 3)Ended earlyNCT00601276What this trial is testingComparison of Two Pharmacological Treatments of PedophiliaWho this might be right forPedophilia Institut National de la Santé Et de la Recherche Médicale, France 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT03419234What this trial is testingAbiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With DocetaxelWho this might be right forCastration Levels of TestosteroneCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma in the Soft Tissue+2 more ECOG-ACRIN Cancer Research Group 223